Refractory cytopenia with multilineage dysplasia
| Refractory cytopenia with multilineage dysplasia | |
|---|---|
| Classification and external resources | |
| ICD-O | MM9985/3 |
Refractory cytopenia with multilineage dysplasia is a form of myelodysplastic syndrome.[1]
It is abbreviated "RCMD".[2][3]
References
- ↑ Rosati S, Mick R, Xu F, et al. (January 1996). "Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome". Leukemia 10 (1): 20–6. PMID 8558932.
- ↑ Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D (January 2009). "Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden". Biol. Blood Marrow Transplant. 15 (1): 30–8. doi:10.1016/j.bbmt.2008.10.012. PMID 19135940.
- ↑ Hamdi W, Ogawara H, Handa H, Tsukamoto N, Nojima Y, Murakami H (November 2008). "Clinical significance of regulatory T cells in patients with myelodysplastic syndrome". Eur. J. Haematol. 82 (3): 201–7. doi:10.1111/j.1600-0609.2008.01182.x. PMID 19018862.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Wednesday, September 02, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.